BioCentury
ARTICLE | Financial News

CEPH, IMCL, IVGN added to NASDAQ-100

December 17, 2001 8:00 AM UTC

Neurology and cancer company Cephalon (CEPH); cancer play ImClone (IMCL); and reagent supplier Invitrogen (IVGN) will be added on Monday Dec. 24 to the NASDAQ-100 Index, which consists of the 100 larg...